Chapter 11 Moral Neuroenhancement
dc.contributor.author | Douglas, Thomas | |
dc.contributor.author | D. Earp, Brian | |
dc.contributor.author | Savulescu, Julian | |
dc.date.accessioned | 2019-10-18 14:17:05 | |
dc.date.accessioned | 2020-04-01T13:03:18Z | |
dc.date.accessioned | 2018-02-28 23:55 | |
dc.date.accessioned | 2019-10-18 14:17:05 | |
dc.date.accessioned | 2020-04-01T13:03:18Z | |
dc.date.accessioned | 2018-02-01 23:55:55 | |
dc.date.accessioned | 2019-10-18 14:17:05 | |
dc.date.accessioned | 2020-04-01T13:03:18Z | |
dc.date.available | 2020-04-01T13:03:18Z | |
dc.date.issued | 2018 | |
dc.identifier | 644654 | |
dc.identifier | OCN: 1030820993 | en_US |
dc.identifier.uri | http://library.oapen.org/handle/20.500.12657/30625 | |
dc.description.abstract | In recent years, philosophers, neuroethicists, and others have become preoccupied with “moral enhancement.” Very roughly, this refers to the deliberate moral improvement of an individual’s character, motives, or behavior. In one sense, such enhancement could be seen as “nothing new at all” (Wiseman, 2016, 4) or as something philosophically mundane: as G. Owen Schaefer (2015) has stated, “Moral enhancement is an ostensibly laudable project. . . . | |
dc.language | English | |
dc.subject.classification | thema EDItEUR::M Medicine and Nursing::MB Medicine: general issues::MBP Health systems and services::MBPK Mental health services | en_US |
dc.subject.other | motives | |
dc.subject.other | moral improvement | |
dc.subject.other | behaviour | |
dc.subject.other | character | |
dc.subject.other | individuals | |
dc.subject.other | motives | |
dc.subject.other | moral improvement | |
dc.subject.other | behaviour | |
dc.subject.other | character | |
dc.subject.other | individuals | |
dc.subject.other | Akrasia | |
dc.subject.other | Augmentative | |
dc.subject.other | Empathy | |
dc.subject.other | Ethics | |
dc.subject.other | Morality | |
dc.subject.other | Mos maiorum | |
dc.subject.other | Neuroenhancement | |
dc.subject.other | Neurotechnology | |
dc.subject.other | Psilocybin | |
dc.title | Chapter 11 Moral Neuroenhancement | |
dc.type | chapter | |
oapen.relation.isPublishedBy | 7b3c7b10-5b1e-40b3-860e-c6dd5197f0bb | |
oapen.relation.isPartOfBook | 6fc18836-6d40-4896-bf56-782f30cd9c99 | |
oapen.relation.isFundedBy | d859fbd3-d884-4090-a0ec-baf821c9abfd | |
oapen.relation.isbn | 9781315708652 | |
oapen.collection | Wellcome | |
oapen.imprint | Routledge | |
oapen.pages | 21 | |
oapen.chapternumber | 1 | |
oapen.remark.public | Relevant Wikipedia pages: Akrasia - https://en.wikipedia.org/wiki/Akrasia; Augmentative - https://en.wikipedia.org/wiki/Augmentative; Empathy - https://en.wikipedia.org/wiki/Empathy; Ethics - https://en.wikipedia.org/wiki/Ethics; Moral agency - https://en.wikipedia.org/wiki/Moral_agency; Morality - https://en.wikipedia.org/wiki/Morality; Mos maiorum - https://en.wikipedia.org/wiki/Mos_maiorum; Neuroenhancement - https://en.wikipedia.org/wiki/Neuroenhancement; Neurotechnology - https://en.wikipedia.org/wiki/Neurotechnology; Psilocybin - https://en.wikipedia.org/wiki/Psilocybin | |
oapen.remark.public | 3-8-2020 - No DOI registered in CrossRef for ISBN 9781138898295 | |
oapen.identifier.ocn | 1030820993 |